In subgroup analysis according to anti-diabetic medications, interaction analysis did not find any significance, contrary to previous studies which showed sulfonylurea increases glucose fluctuation and risk of hypoglycemia [33], and DPP-4 inhibitors and the novel insulin analogue degludec reduced GV [34–36]. The gene discussed is DPP4; the disease is Hypoglycemia.